Literature DB >> 22793523

The decreased CD4+CD25+ FoxP3+ T cells in nonstimulated allergic rhinitis patients sensitized to house dust mites.

Sema Genc1, Hacer Eroglu, Umut Can Kucuksezer, Esin Aktas-Cetin, Asli Gelincik, Esra Ustyol-Aycan, Suna Buyukozturk, Gunnur Deniz.   

Abstract

OBJECTIVE: Regulatory (CD4(+)CD25(+)) T cells have been shown to play an important role in the development of allergic diseases. This study aims to investigate CD4(+)CD25(+) T cells, Forkhead box P3 (FoxP3(+) cells), and T-helper 1/T-helper 2 (Th1/Th2) cytokines in newly diagnosed allergic rhinitis (AR) patients.
METHODS: Altogether, 10 subjects with AR and 12 age-matched nonallergic healthy subjects were included in this study. CD4(+)CD25(+) T cells, FoxP3(+) T cells in peripheral blood mononuclear cells (PBMCs) were evaluated by flow cytometry, and the Th1/Th2 cytokine levels were determined by cytometric bead array immunoassay in both PBMC supernatants and nasal lavage fluids.
RESULTS: The percentage of CD4(+)CD25(+) T cells were significantly higher, whereas the percentage of FoxP3(+) cells were lower in AR patients compared with healthy subjects. In PBMC culture supernatants, interleukin-10 (IL-10) levels were significantly lower (p = .012), whereas IL-4, IL-5, and tumor necrosis factor-α (TNF-α) levels in nasal lavage fluids were higher in AR patients compared with healthy subjects (p = .026, p = .015, p = .03, respectively).
CONCLUSIONS: Our findings indicate that decrease in CD4(+)CD25(+)FoxP3(+) T cell fraction and diminished levels of IL-10 are noteworthy without allergen stimulation in house dust mite AR patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22793523     DOI: 10.3109/02770903.2012.695418

Source DB:  PubMed          Journal:  J Asthma        ISSN: 0277-0903            Impact factor:   2.515


  8 in total

1.  Immunomodulatory Effects of Adjuvants CPG, MPLA, and BCG on the Derp2-Induced Acute Asthma at Early Life in an Animal Model of BALB/c Mice.

Authors:  V Mohammadi-Shahrokhi; A Rezaei; A Andalib; A Rahnama; A Jafarzadeh; N Eskandari
Journal:  Inflammation       Date:  2017-02       Impact factor: 4.092

Review 2.  T helper subsets in allergic eye disease.

Authors:  Nancy J Reyes; Daniel R Saban
Journal:  Curr Opin Allergy Clin Immunol       Date:  2014-10

3.  The role of regulatory T cells in allergic rhinitis and their correlation with IL-10, IL-17 and neopterin levels in serum and nasal lavage fluid.

Authors:  Kadriye Erkan; Mete K Bozkurt; Hasibe Artaç; Hülya Özdemir; Ali Ünlü; Emine N Korucu; Çağdaş Elsürer
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-01-28       Impact factor: 2.503

4.  The role of regulatory T cells in the regulation of upper airway inflammation.

Authors:  Charlie Palmer; Jennifer K Mulligan; Sarah E Smith; Carl Atkinson
Journal:  Am J Rhinol Allergy       Date:  2017-11-01       Impact factor: 2.300

5.  Induction of tumor necrosis factor (TNF) release from subtypes of T cells by agonists of proteinase activated receptors.

Authors:  Haiwei Yang; Tao Li; Jifu Wei; Huiyun Zhang; Shaoheng He
Journal:  Mediators Inflamm       Date:  2013-12-16       Impact factor: 4.711

6.  Prostaglandin E2 signal inhibits T regulatory cell differentiation during allergic rhinitis inflammation through EP4 receptor.

Authors:  Lisha Li; Kai Guan; Yu Zhou; Jia Wu; Yan Wang; Wei Wang
Journal:  World Allergy Organ J       Date:  2019-11-29       Impact factor: 4.084

7.  Taurine promotes the production of CD4+CD25+FOXP3+ Treg cells through regulating IL-35/STAT1 pathway in a mouse allergic rhinitis model.

Authors:  Jing Zhou; Yi Lu; Wei Wu; Yunhai Feng
Journal:  Allergy Asthma Clin Immunol       Date:  2021-06-19       Impact factor: 3.406

8.  An imbalance between frequency of CD4+CD25+FOXP3+ regulatory T cells and CCR4+ and CCR9+ circulating helper T cells is associated with active perennial allergic conjunctivitis.

Authors:  J Galicia-Carreón; C Santacruz; J Ayala-Balboa; A Robles-Contreras; S M Perez-Tapia; Y Garfias; E Hong; M C Jiménez-Martínez
Journal:  Clin Dev Immunol       Date:  2013-12-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.